Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Mark D. Topazian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1090-2844; OpenAlex author ID A5046429346; NIH RePORTER profile ID 6367050. Sources: ClinicalTrials.gov.

Their work

Papers
13
Trials
1 (principal investigator on 1)
Grants
2
Labs led
0
Collaborators
81
Papers, trials and grants by year

2004: 1 trial · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 3 papers · 2019: 3 papers · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 grant · 2025: none · 2026: 1 paper, 1 grant

Papers 13

  1. Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for the Study of Chronic Pancreatitis, Diabet… Co-author DOI 10.1097/mpa.0000000000002657↗
  2. Endoscopic pancreatic duct stenting for pain palliation in selected pancreatic cancer patients: a systematic review and meta-analysis. Co-author DOI 10.1093/gastro/goab001↗
  3. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. Co-author DOI 10.1016/j.cgh.2019.07.017↗
  4. Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2019.11.003↗
  5. Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for t… Co-author DOI 10.1007/s00261-019-02049-5↗
  6. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Canc… Co-author DOI 10.1038/s41395-018-0403-2↗
  7. Reporting Standards for Chronic Pancreatitis by Using CT, MRI, and MR Cholangiopancreatography: The Consortium for the Study of Chronic Pancreatitis, Diabetes,… Co-author DOI 10.1148/radiol.2018181353↗
  8. Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.01.049↗
  9. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the … Co-author DOI 10.1097/mpa.0000000000001170↗
  10. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pan… Co-author DOI 10.1097/mpa.0000000000001171↗
  11. Endoscopic Ultrasound Fine-Needle Aspiration Diagnosis of Synchronous Primary Pancreatic Adenocarcinoma and Effects on Staging and Resectability. Co-author DOI 10.1016/j.cgh.2016.08.009↗
  12. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.gie.2014.12.036↗
  13. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Co-author DOI 10.1016/j.cgh.2012.11.016↗

Trials 1

  1. Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms Principal investigator NCT02158039↗

Grants 2

  1. The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer U01DK108288↗
  2. The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center U01DK108327↗

Closest collaborators

The 25 strongest of 81 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Santhi Swaroop Vege · 6 shared papers, 1 shared grant, 2015–2026 · strength 1.41
  2. Suresh T. Chari · 7 shared papers, 1 shared grant, 2015–2026 · strength 1.33
  3. Gloria M. Petersen · 1 shared paper, 1 shared grant, 2020–2026 · strength 0.94
  4. Darwin Lewis Conwell · 5 shared papers, 1 shared grant, 2018–2026 · strength 0.90
  5. Melena D. Bellin · 1 shared paper, 1 shared grant, 2024–2026 · strength 0.62
  6. Dhiraj Yadav · 5 shared papers, 2018–2026 · strength 0.51
  7. David Clement Whitcomb · 2 shared papers, 1 shared grant, 2018–2024 · strength 0.51
  8. Temel Tirkes · 4 shared papers, 2018–2026 · strength 0.46
  9. Evan L Fogel · 4 shared papers, 2018–2026 · strength 0.46
  10. Walter Gwang-Up Park · 4 shared papers, 2018–2026 · strength 0.46
  11. Hanno Steen · 1 shared paper, 1 shared grant, 2018–2024 · strength 0.45
  12. José Serrano · 4 shared papers, 2018–2026 · strength 0.43
  13. Stephen Jacob Pandol · 4 shared papers, 2018–2026 · strength 0.43
  14. Michael J. Levy · 6 shared papers, 2015–2020 · strength 0.41
  15. Philip A. Hart · 1 shared grant, 2024 · strength 0.39
  16. Andres Gelrud · 1 shared grant, 2024 · strength 0.39
  17. Pamela G. Banks · 1 shared grant, 2024 · strength 0.39
  18. Cheryl E Gariepy · 1 shared grant, 2024 · strength 0.39
  19. Francis G Gress · 1 shared grant, 2024 · strength 0.39
  20. Joseph Palermo · 1 shared grant, 2024 · strength 0.39
  21. Peter Alan Banks · 1 shared grant, 2024 · strength 0.39
  22. Phil A. Hart · 3 shared papers, 2018–2026 · strength 0.34
  23. Ferga C. Gleeson · 5 shared papers, 2015–2020 · strength 0.34
  24. Naoki Takahashi · 4 shared papers, 2018–2020 · strength 0.32
  25. Christopher E Forsmark · 2 shared papers, 2018–2026 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.